Tag: Healthcare
NYU School of Global Public Health Wins STAT Madness Vote
In a spirited celebration of scientific discovery, the recent STAT Breakthrough Summit East in Manhattan hosted a unique event that drew parallels to the...
Dr. Oz Advocates for AI in Congress
Dr. Oz Champions AI in Congressional HearingIn a recent Senate Finance Committee confirmation hearing, Dr. Mehmet Oz, nominated by President Donald Trump to lead...
Mass General Brigham vs. Dana-Farber: Hospital Battle Unveiled
A battle is brewing behind the scenes in the world of healthcare, as the future of cancer care hangs in the balance. The clash...
UnitedHealth’s AI care denials lawsuit allowed to proceed
In a recent turn of events, Medicare Advantage beneficiaries who believe they were wrongfully denied care by UnitedHealth Group's algorithm have reason to celebrate....
Threat to Pharmaceutical Public-Private Partnerships: Gilead’s Short-Term Win
In December 2024, a group of legal, medical, and public health experts united to file an amicus brief in support of the U.S. government...
The Main Target and Focus: The article focuses on key figures attending the J.P....
Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures...
Understanding Palliative Care: Insights from a Professional | NIH MedlinePlus Magazine
Understanding Palliative Care: A Compassionate GuideIn the realm of healthcare, when serious or terminal illnesses strike, patients and their families are often left grappling...
Narcan: Over-the-Counter Lifesaving Opioid Overdose Reversal Drug
Narcan: The Groundbreaking Over-the-Counter Opioid Overdose Reversal DrugThe Food and Drug Administration has taken a monumental step in the fight against opioid overdoses by...
FDA Approval: Ionis Rare Disease Therapy Lowers Triglycerides
Ionis Pharmaceuticals has achieved a significant milestone by obtaining FDA approval for their groundbreaking therapy, Tryngolza, designed to combat a rare and fatal genetic...
Boosting Tuberculosis Research Funding: Progress Made, But Still Short of Goals.
Progress in Tuberculosis Research Funding Still Falls Short of GoalsIn a recent report, it was revealed that despite reaching new heights in research and...
Bristol Myers Files Lawsuit Against HHS Over 340B Hospital Payment Terms
Bristol Myers Squibb recently filed a lawsuit against the Department of Health and Human Services (HHS), claiming that the Biden administration is unlawfully preventing...
Reining in AI Use in Medicare Advantage: Biden Administration’s Plan
The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence,...